NO177708C - Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav - Google Patents

Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav

Info

Publication number
NO177708C
NO177708C NO902071A NO902071A NO177708C NO 177708 C NO177708 C NO 177708C NO 902071 A NO902071 A NO 902071A NO 902071 A NO902071 A NO 902071A NO 177708 C NO177708 C NO 177708C
Authority
NO
Norway
Prior art keywords
analogs
intermediates
preparation
acetic acids
oxophthalazinyl acetic
Prior art date
Application number
NO902071A
Other languages
English (en)
Norwegian (no)
Other versions
NO177708B (no
NO902071L (no
NO902071D0 (no
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO902071D0 publication Critical patent/NO902071D0/no
Publication of NO902071L publication Critical patent/NO902071L/no
Publication of NO177708B publication Critical patent/NO177708B/no
Publication of NO177708C publication Critical patent/NO177708C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO902071A 1989-05-11 1990-05-10 Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav NO177708C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,997 US4954629A (en) 1989-05-11 1989-05-11 Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Publications (4)

Publication Number Publication Date
NO902071D0 NO902071D0 (no) 1990-05-10
NO902071L NO902071L (no) 1990-11-12
NO177708B NO177708B (no) 1995-07-31
NO177708C true NO177708C (no) 1995-11-08

Family

ID=23379152

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902071A NO177708C (no) 1989-05-11 1990-05-10 Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav

Country Status (30)

Country Link
US (1) US4954629A (xx)
EP (1) EP0397350B1 (xx)
JP (1) JPH035479A (xx)
KR (1) KR920006419B1 (xx)
CN (1) CN1025855C (xx)
AR (1) AR246968A1 (xx)
AT (1) ATE103913T1 (xx)
AU (2) AU618898B2 (xx)
BG (1) BG50609A3 (xx)
CA (1) CA2016504C (xx)
CZ (1) CZ281213B6 (xx)
DD (1) DD294257A5 (xx)
DE (1) DE69007846T2 (xx)
DK (1) DK0397350T3 (xx)
EG (1) EG19082A (xx)
ES (1) ES2063265T3 (xx)
FI (1) FI93959C (xx)
HU (1) HU212304B (xx)
IE (1) IE62591B1 (xx)
IL (3) IL114271A (xx)
MX (2) MX167455B (xx)
NO (1) NO177708C (xx)
NZ (1) NZ233597A (xx)
PH (1) PH26567A (xx)
PL (1) PL164427B1 (xx)
PT (1) PT93985B (xx)
RO (1) RO107256B1 (xx)
RU (1) RU2014333C1 (xx)
YU (1) YU91290A (xx)
ZA (1) ZA903565B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
DK3597650T3 (da) * 2010-07-16 2022-11-21 Univ Columbia Aldosereduktasehæmmere og anvendelser deraf
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
CN102558184B (zh) * 2011-12-30 2014-07-16 西南大学 酞嗪类衍生物的合成方法
CN102702108A (zh) * 2012-06-27 2012-10-03 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN102863393A (zh) * 2012-09-26 2013-01-09 上海大学 1,2-二氢酞嗪类化合物及其合成方法
CN115160339B (zh) 2016-06-21 2024-05-14 纽约市哥伦比亚大学理事会 醛糖还原酶抑制剂及其使用方法
MX2020001057A (es) 2017-07-28 2020-11-24 Applied Therapeutics Inc Composiciones y metodos para tratar la galactosemia.
EP3947391A1 (en) 2019-04-01 2022-02-09 Applied Therapeutics Inc. Inhibitors of aldose reductase

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
DE3337859A1 (de) * 1983-01-21 1984-07-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von benzthiazolen
CA1299178C (en) * 1985-11-07 1992-04-21 Banavara Lakshmana Mylari Heterocyclic oxophtalazinyl acetic acids
EP0222576B1 (en) * 1985-11-07 1992-03-18 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4996204A (en) * 1989-05-11 1991-02-26 Pfizer Inc. Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Also Published As

Publication number Publication date
ZA903565B (en) 1991-12-24
DK0397350T3 (da) 1994-05-09
HU212304B (en) 1996-05-28
CA2016504C (en) 1999-07-27
RU2014333C1 (ru) 1994-06-15
DE69007846D1 (de) 1994-05-11
NZ233597A (en) 1992-02-25
CN1047499A (zh) 1990-12-05
JPH035479A (ja) 1991-01-11
FI93959B (fi) 1995-03-15
CZ281213B6 (cs) 1996-07-17
IL94301A (en) 1996-01-19
BG50609A3 (en) 1992-09-15
NO177708B (no) 1995-07-31
IE62591B1 (en) 1995-02-08
FI93959C (fi) 1995-06-26
EG19082A (en) 1994-07-30
US4954629A (en) 1990-09-04
IL94301A0 (en) 1991-03-10
MX167455B (es) 1993-03-23
RO107256B1 (ro) 1993-10-30
CN1025855C (zh) 1994-09-07
AU5490690A (en) 1990-11-15
CZ227890A3 (en) 1996-04-17
IE901626L (en) 1990-11-11
NO902071L (no) 1990-11-12
CA2016504A1 (en) 1990-11-11
AU8680691A (en) 1992-01-02
HU902995D0 (en) 1990-09-28
ATE103913T1 (de) 1994-04-15
AU626225B2 (en) 1992-07-23
PT93985B (pt) 1996-11-29
JPH0573753B2 (xx) 1993-10-15
EP0397350A1 (en) 1990-11-14
ES2063265T3 (es) 1995-01-01
PL285113A1 (en) 1991-07-15
PH26567A (en) 1992-08-19
YU91290A (sh) 1992-09-07
KR900018114A (ko) 1990-12-20
IL114271A (en) 1998-04-05
MX9207687A (es) 1994-06-30
EP0397350B1 (en) 1994-04-06
IL114271A0 (en) 1995-10-31
AU618898B2 (en) 1992-01-09
PT93985A (pt) 1991-01-08
FI902333A0 (fi) 1990-05-10
DE69007846T2 (de) 1994-07-28
PL164427B1 (pl) 1994-07-29
DD294257A5 (de) 1991-09-26
NO902071D0 (no) 1990-05-10
HUT54690A (en) 1991-03-28
KR920006419B1 (ko) 1992-08-06
AR246968A1 (es) 1994-10-31

Similar Documents

Publication Publication Date Title
PL285590A1 (en) Method of obtaining novel imidazolilalkenic acids
FI883997A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 2-fenyyli-4-kinoliinikarboksyylihappojen valmistamiseksi
DK293590D0 (da) Fermenteringsfremgangsmaade til fremstilling af carboxylsyrer
IL89535A0 (en) Process and novel intermediates for the preparation of 1-cyclopropyl-quinolone-carboxylic acids and their derivatives
NO177708C (no) Fremgangsmåte og mellomprodukter for fremstilling av oksoftalazinyl-eddiksyrer og analoger derav
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
IT1165574B (it) Processo per la preparazione di anidride acetica
IT8048995A0 (it) Procedimento per la preparazione di acidi alcanoici
IT1165573B (it) Processo per la preparazione di anidride acetica
NO911892L (no) Fremgangsmaate for fremstilling og anvendelse av alfa-oksopypyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
IT1134999B (it) Procedimento per preparare esteri alchilici di acidi c-alchil-tartronici o c-alogenoalchil-tartronici
FR2611201B1 (fr) Intermediaires de tetrazole et procede de preparation de derives antihypercholesterolemiques du tetrazole
FI901550A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten di-imidatsopyrimidiini- ja imidatsopyratsolopyrimidiinijohdannaisten valmistamiseksi
NO175859C (no) Fremgangsmåte for fremstilling av kinolincarboxylsyrer
PT86636A (pt) Process for the preparation of azetidine and of novel intermediates therefor
NO177307C (no) Fremgangsmåte for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoatestere
FI945119A0 (fi) Menetelmä 3(S)-metyyliheptaanihapon valmistamiseksi ja välituotteet
ZA897782B (en) Process for the preparation of 7-substituted-hept-6-enoic and-haptanoic acids and derivatives and intermediates thereof
ES531976A0 (es) Procedimiento de preparacion de acidos aceticos sustituidos
HRP940502B1 (en) Process for the preparation of new substituted alkanediphosphonic acids
IT1155428B (it) Procedimento per la preparazione di esteri e acidi n-alchil-2-(pirril-2)-gliossilici e acetici
ITMI921715A0 (it) Procedimento per la preparazione di acidi alogenobenzoici
BA98212B1 (bs) Postupak za dobijanje heterociklicnih oksoftalazinil sircetnih kiselina
PL291625A1 (en) Method of obtaining novel acetic ester
IT1240228B (it) Preparazione di acidi alfa-metilarenacetici.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2001